Ignite Creation Date:
2024-05-06 @ 7:32 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02558387
Status:
UNKNOWN
Last Update Posted:
2015-11-20
First Post:
2015-09-22
Brief Title:
Trial of BIBF1120 Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11
Start Date Type:
None
Primary Completion Date:
2016-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-01
Completion Date Type:
ESTIMATED
First Submit Date:
2015-09-22
First Submit QC Date:
September 23 2015
Study First Post Date:
2015-09-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-11-18
Last Update Post Date:
2015-11-20
Last Update Post Date Type:
ESTIMATED